Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
4
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
4
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
donald trump
drug prices
loxo oncology
allergan
approval
bristol-myers squibb
car-t
celgene
clinical study
democrats
What
bio
cancer
drugs
notes
roundup
afternoon
airport
allogene
annual
anticipated
apocalypse
appetite
awaited
beds
black
blueprint
bread
butter
buyout
cash
celgene
cost
crispr
cut
days
details
diabetes
diamond’s
diversity
drug
eli
fallout
giant
gone
grabbed
hasn’t
hold
home
hot
house
Language
Current search:
medicare
×
" national blog main "
×
fda
×
" scott gottlieb "
×
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details